Back to search

Sweden· SE-20180813000030

Femostonconti 0,5 mg/2,5 mg Filmdragerad tablett

A medicinal product containing dydrogesterone + estradiol, registered in Sweden by Theramex Ireland Limited.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedFemostonconti 0,5 mg/2,5 mg Filmdrage…ATC—REGISTER NO.SE-20180813000030PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Dydrogesterone + Estradiol
Manufacturer
Theramex Ireland Limited
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20180813000030

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Dydrogesterone + estradiol in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dydrogesterone + estradiol products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

  • Austria · Femoston, Femoston Conti
  • Belgium · Femoston, Femoston 2/10
  • Cyprus · Femoston
  • Czechia · Femoston, Femoston Conti
  • Germany · Femoston, Femoston Conti
  • Denmark · Femoston, Femoston Conti
  • Estonia · Femoston, Femoston Conti
  • Spain · Femfascon, Femoston
  • Finland · Femoston, Femoston Conti
  • France · Climaston
  • Greece · Femaston
  • Croatia · Femoston, Femoston Conti
  • Ireland · Femoston, Femoston-Conti
  • Italy · Femoston, Femoston Conti
  • Lithuania · Femoston, Femoston Conti
  • Luxembourg · Femoston, Femoston Conti
  • Latvia · Femoston, Femoston Conti
  • Malta · Femoston, Femoston-Conti
  • Netherlands · Femoston, Femoston Continu
  • Norway · Femoston, Femostonconti
  • Poland · Femoston, Femoston Conti
  • Portugal · Femoston
  • Slovenia · Femphascon Conti
  • Slovakia · Femoston, Femoston Conti

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f261179c-dc2c-417d-9b9f-25a0a6e12305
GET /v1/drugs/f261179c-dc2c-417d-9b9f-25a0a6e12305?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "SmPC",
    "PL"
  ],
  "se_npl_id": "20180813000030",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20180813000030",
  "product_doc_link": "https://docetp.mpa.se/LMF/Femostonconti%200.5%20mg_2.5%20mg%20film-coated%20tablet%20SmPC_09001bee807a2a8e.pdf"
}

See everything about dydrogesterone + estradiol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.